Engineered nanomedicines block the PD-1/PD-L1 axis for potentiated cancer immunotherapy
Junhao Li, Lujia Huang, Huiling Zhou, Yi-ming Shan, Fangmin Chen, Vesa‐Pekka Lehto, Wujun Xu, Liqiang Luo, Haijun Yu
Topics & Concepts
PD-L1ImmunotherapyMedicineBlockadeCancer immunotherapyCytotoxic T cellImmune checkpointCancer therapyCancerTargeted therapyImmune systemCancer researchCombination therapyImmunologyOncologyPharmacologyInternal medicineBiologyReceptorIn vitroBiochemistryCancer Immunotherapy and BiomarkersNanoplatforms for cancer theranosticsImmune cells in cancer